Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (122)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1287 result(s) found, displaying 1251 to 1275
-
-
Market actions
-
Market actionsIn 2003, the TGA recalled Pan Pharmaceuticals’ products due to serious safety and manufacturing issues.
-
Market actions
-
Market actions
-
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Market actions
-
Safety alertsBotanicLab herbal supplements contain undeclared prescription drugs and are not registered in Australia. Stop using them and consult your doctor for advice.
-
Safety alertsDo not use homoeopathic meningococcal 'vaccines' as they don't protect against the disease. Use approved vaccines and talk to your doctor if you have any questions.
-
Safety alertsKava-containing medicines are under review due to reports of liver damage, and a voluntary recall has been initiated while we assess their safety.
-
Market actions
-
Safety alertsWe are advising that long-term use of oestrogen-only therapy may increase the risk of ovarian cancer. Consult your doctor if you have concerns.
-
Market actions
-
Safety alertsThe Expert Committee has reviewed the safety of HRT and found increased risks of heart attacks, strokes, blood clots, and breast cancer, outweighing the benefits for long-term disease prevention
-
-
-
Safety alertsConsumers are advised to be cautious with kava-containing medicines due to potential liver damage, and should seek medical advice if they experience any symptoms.
-
Safety alertsHealth professionals are alerted to potential liver damage linked to kava-containing medicines, and are asked to review cases of unexplained hepatotoxicity.
-
Market actions